They have shown reasonable accuracy in diagnosing advanced fibrosis and good performance in excluding the majority of patients with a low risk of liver-related complications
The semaglutide results showed a much higher lean share, raising alarms among experts
This may make your treatment with Ozempic harder, no matter the dose
Research published in January 2026 finds that people who stopped taking weight-loss drugs return to their original weight and forgo any benefits gained within two years
Meanwhile, GLP-1RAs showed a trend towards a reduced risk for nine respiratory diseases, although not reaching statistical significance, including pneumonia (RR 0.89, 95% CI 0.781.00, p = 0.05
Furthermore, reduced food intake resulting from the medications appetite-suppressing effects may lead to less digestive bulk and harder stools